Andrew Guggenhime - 05 Sep 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
President and CFO
Signature
Andrew Guggenhime, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
05 Sep 2023
Net transactions value
-$181,968
Form type
4
Filing time
06 Sep 2023, 17:34:34 UTC
Previous filing
03 Mar 2023
Next filing
20 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability $181,968 -3,568 -4.3% $51.00 79,474 05 Sep 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.
F2 Includes 1,040 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2023.